Peng-Ju Chen, Lin Wang, Ting-Ting Sun, Yun-Feng Yao, Yi-Fan Peng, Jun Zhao, Tian-Cheng Zhan, Jia-Hua Leng, Yong Cai, Yong-Heng Li, Xiao-Yan Zhang, Ying-Shi Sun, Zhong-Wu Li, Wei-Hu Wang, Ai-Wen Wu
BACKGROUND: Induction chemotherapy combined with neoadjuvant chemoradiotherapy has been recommended for patients with high-risk, locally advanced rectal cancer. However, the benefit of more intensive total neoadjuvant treatment (TNT) is unknown. This study aimed to assess the safety and efficacy of induction chemotherapy combined with chemoradiotherapy and consolidation chemotherapy for magnetic resonance imaging-stratified high-risk rectal cancer. METHODS: This was a single-center, single-arm, prospective Phase II trial in Peking University Cancer Hospital (Beijing, China)...
2023: Gastroenterology Report